Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects

doi:10.3748/wjg.v25.i32.4682

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9285)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

782

WORD

245

HTML

6505

Figures (1-3)

153

Tables (1-2)

152

Sum=7837

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

692

Download

756

Sum=1448

Aug 28, 2019 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (55)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 28, 2019; 25(32): 4682-4695
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4682

Open in New Tab Full Size Figure Download Figure

Figure 1 2-Deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography detected tumor recurrence after intervention therapy in a 58-year-old male patient with hepatocellular carcinoma. A: Cross-sectional computed tomography (CT) image showing a large sheet of lipiodol deposition in the right lobe of live after HCC intervention therapy; B: Cross-sectional positron-emission tomography (PET-CT) fusion image showing increased ¹⁸F-FDG uptake in and around the area of lipiodol deposition (blue arrow); the size of the lesion was 5.8 × 13.3 cm; C: Cross-sectional PET image showing increased ¹⁸F-FDG uptake in the right lobe of the liver; D: Maximum intensity projection image showing increased ¹⁸F-FDG uptake in the right lobe of the liver. ¹⁸F-FDG: 2-deoxy-2-(¹⁸F)fluoro-D-glucose; CT: Computed tomography; PET: Positron-emission tomography.

Open in New Tab Full Size Figure Download Figure

Figure 2 ¹¹C-choline positron-emission tomography-computed tomography detected a tumor that was missed on conventional 2-deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography in a 58-year-old patient with hepatocellular carcinoma. A-D: 2-deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography (¹⁸F-FDG PET-CT) showed that there was no increased ¹⁸F-FDG uptake in the liver; E-H: ¹¹C-choline (¹¹C-CHOL) PET-CT showed focal increased ¹¹C-CHOL uptake in the upper segment of the anterior lobe of the liver, and the size of the lesion was 1.2 × 1.3 cm (blue arrow in F and G). Pathological examination confirmed well-differentiated hepatocellular carcinoma. ¹⁸F-FDG: 2-deoxy-2-(¹⁸F)fluoro-D-glucose; CT: Computed tomography; PET: Positron-emission tomography; ¹¹C-CHOL: ¹¹C-choline.

Open in New Tab Full Size Figure Download Figure

Figure 3 Early dynamic 2-deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography detected a tumor that was missed on conventional 2-deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography in a 64-year-old patient with hepatocellular carcinoma. A-D: 2-deoxy-2-(¹⁸F)fluoro-D-glucose positron-emission tomography-computed tomography (¹⁸F-FDG PET-CT) showed that there was no increased ¹⁸F-FDG uptake in the lesion on conventional ¹⁸F-FDG PET-CT; E-H: Early dynamic ¹⁸F-FDG PET-CT showed focal ¹⁸F-FDG hyperperfusion in the upper segment of the anterior lobe of the liver, and the size of the lesion was 1.7 × 1.9 cm (blue arrow in F and G). ¹⁸F-FDG: 2-deoxy-2-(¹⁸F)fluoro-D-glucose; CT: Computed tomography; PET: Positron-emission tomography.

Citation: Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695
URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4682.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4682